The DOI matches its Crossref record; 277 of the 277 references it cites were found in a registry or an index.
Modulating the endocannabinoid system in human health and disease – successes and failures
Open accessAbstract
The discovery of the endocannabinoid system, comprising the G‐protein coupled cannabinoid 1 and 2 receptors (CB1/2), their endogenous lipid ligands or endocannabinoids, and synthetic and metabolizing enzymes, has triggered an avalanche of experimental studies implicating the endocannabinoid system in a growing number of physiological/pathological functions. These studies have also suggested that modulating the activity of the endocannabinoid system holds therapeutic promise for a broad range of diseases, including neurodegenerative, cardiovascular and inflammatory disorders; obesity/metabolic syndrome; cachexia; chemotherapy‐induced nausea and vomiting; and tissue injury and pain, amongst others. However, clinical trials with globally acting CB1 antagonists in obesity/metabolic syndrome, and other studies with peripherally‐restricted CB1/2 agonists and inhibitors of the endocannabinoid metabolizing enzyme in pain, have introduced unexpected complexities, suggesting that a better understanding of the pathophysiological role of the endocannabinoid system is required to devise clinically successful treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–277 of 277
The peripheral cannabinoid receptor knockout mice: an update
Buckley, N. E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707527 · Cited by 115
Endocannabinoids and the Control of Energy Homeostasis
Kunos, G., Osei‐Hyiaman, D., Liu, J., Godlewski, G., & Bátkai, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800012200 · Cited by 114
Self-citationCB2 receptors as new therapeutic targets for liver diseases
Lotersztajn, S., Teixeira-Clerc, F., Julien, B., Deveaux, V., Ichigotani, Y., Manin, S., Nhieu, J. T. V., Karsak, M., Zimmer, A., & Mallat, A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707511 · Cited by 114
Endocannabinoids and Liver Disease. I. Endocannabinoids and their receptors in the liver
Mallat, A., & Lotersztajn, S. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00467.2007 · Cited by 113
Role of Cannabinoids and Endocannabinoids in Cerebral Ischemia
Hillard, C. J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740054 · Cited by 113
Nackley, A. G., Zvonok, A. M., Makriyannis, A., & Hohmann, A. G. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00886.2003 · Cited by 112
Cannabinoids Ameliorate Pain and Reduce Disease Pathology in Cerulein-Induced Acute Pancreatitis
Michalski, C. W., Laukert, T., Sauliunaite, D., Pacher, P., Bergmann, F., Agarwal, N. K., Su, Y. Y., Giese, T., Giese, N. A., Bátkai, S., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.035 · Cited by 112
Self-citationCabral, G. A., & Staab, A. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-26573-2_13 · Cited by 108
Gatta, L., Piscitelli, F., Giordano, C., Boccella, S., Lichtman, A. H., Maione, S., & Marzo, V. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031111 · Cited by 108
Cannabinoids and Atherosclerotic Coronary Heart Disease
Singla, S., Sachdeva, R., & Mehta, J. L. (2012) · Clinical Cardiology · doi:10.1002/clc.21962 · Cited by 107
Nackley, A. G., Suplita, R. L., & Hohmann, A. G. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00870-9 · Cited by 104
Cannabinoids and the skeleton: From marijuana to reversal of bone loss
Bab, I., Zimmer, A. D., & Melamed, E. (2009) · Annals of Medicine · doi:10.1080/07853890903121025 · Cited by 103
Cannabinoids in intestinal inflammation and cancer
Izzo, A. A., & Camilleri, M. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.03.008 · Cited by 103
Marijuana use and long-term mortality among survivors of acute myocardial infarction
Frost, L. E., Mostofsky, E., Rosenbloom, J. I., Mukamal, K. J., & Mittleman, M. A. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.11.007 · Cited by 101
Borrelli, F., & Izzo, A. A. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.003 · Cited by 100
Fatty Acid Amide Hydrolase: A Gate-Keeper of the Endocannabinoid System
Fezza, F., De Simone, C., Amadio, D., & Maccarrone, M. (2008) · Subcellular Biochemistry · doi:10.1007/978-1-4020-8831-5_4 · Cited by 99
Monoacylglycerol lipase – a target for drug development?
Fowler, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01950.x · Cited by 98
An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis
Loría, F., Petrosino, S., Hernangómez, M., Mestre, L., Spagnolo, A., Correa, F., Marzo, V. D., Docagne, F., & Guaza, C. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.09.020 · Cited by 98
Zheng, D., Bode, A. M., Zhao, Q. J., Cho, Y., Zhu, F., Ma, W.-Y., & Dong, Z. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6594 · Cited by 98
Montecucco, F., Marzo, V. D., da Silva, R., Vuilleumier, N., Capettini, L. D. S. A., Lenglet, S., Pagano, S., Piscitelli, F., Quintao, S., Bertolotto, M. B., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr449 · Cited by 97
Godlewski, G., Alapafuja, S. O., Bátkai, S., Nikas, S. P., Cinar, R., Offertáler, L., Osei-Hyiaman, D., Liu, J., Mukhopadhyay, B., Harvey-White, J., et al. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.08.013 · Cited by 95
Self-citationFAAH deficiency promotes energy storage and enhances the motivation for food
Touriño, C., Oveisi, F., Lockney, J., Piomelli, D., & Maldonado, R. J. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.262 · Cited by 94
Bouchard, J., Lépicier, P., & Lamontagne, D. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02474-8 · Cited by 93
Weis, F. C., Beiras-Fernández, A., Sodian, R., Kaczmarek, I., Reichart, B., Beiras, A., Schelling, G., & Kreth, S. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.10.025 · Cited by 89
Annuzzi, G., Piscitelli, F., Marino, L. D., Patti, L., Giacco, R., Costabile, G., Bozzetto, L., Riccardi, G., Verde, R., Petrosino, S., et al. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-43 · Cited by 89
Modulation of the endocannabinoid system: Neuroprotection or neurotoxicity?
Fowler, C. J., Rojo, M. L., & Rodríguez‐Gaztelumendi, A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.021 · Cited by 88
Fowler, C. J. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.01.001 · Cited by 87
Gorelick, D. A., Goodwin, R. S., Schwilke, E. W., Schwope, D. M., Darwin, W. D., Kelly, D. L., McMahon, R. P., Liu, F., Ortemann, C., BONNET, D., et al. (2012) · Journal of Analytical Toxicology · doi:10.1093/jat/bks081 · Cited by 87
Cannabinoid Administration Attenuates the Progression of Simian Immunodeficiency Virus
Molina, P. E., Winsauer, P. J., Zhang, P., Walker, E. M., Birke, L. L., Amedee, A. M., Stouwe, C. V., Troxclair, D. A., McGoey, R. R., Varner, K. J., et al. (2010) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2010.0218 · Cited by 83
Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease
Méndez‐Sánchez, N., Zamora‐Valdés, D., Pichardo-Bahena, R., Barredo-Prieto, B. A., Ponciano‐Rodríguez, G., Bermejo-Martínez, L., Chávez-Tapia, N. C., González, H. A. B., & Uribe, M. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01401.x · Cited by 83
Coronary Vasomotor Control in Obesity and Morbid Obesity
Quercioli, A., Pataky, Z., Montecucco, F., Carballo, S., Thomas, A., Staub, C., Marzo, V. D., Vincenti, G. M., Ambrosio, G., Ratib, O. M., et al. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.01.020 · Cited by 81
Starowicz, K., Makuch, W., Osikowicz, M., Piscitelli, F., Petrosino, S., Marzo, V. D., & Przewłocka, B. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.11.021 · Cited by 80
Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury
Mukhopadhyay, P., Horváth, B., Rajesh, M., Matsumoto, S., Saito, K., Bátkai, S., Patel, V., Tanchian, G., Gao, R. Y., Cravatt, B. F., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.002 · Cited by 80
Self-citationMontecucco, F., Matias, I., Lenglet, S., Petrosino, S., Burger, F., Pelli, G., Braunersreuther, V., Mach, F., Steffens, S., & Marzo, V. D. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.040 · Cited by 77
“Redundancy” of Endocannabinoid Inactivation: New Challenges and Opportunities for Pain Control
Piscitelli, F., & Marzo, V. D. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300015x · Cited by 76
Endocannabinoids and liver disease† ‡
Jiménez, W. (2005) · Hepatology · doi:10.1002/hep.20714 · Cited by 75
Siegmund, S., & Schwabe, R. F. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00456.2007 · Cited by 74
Lim, J. C., Lim, S. K., Han, H. J., & Park, S. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22255 · Cited by 74
The Role of the Endocannabinoid System in Atherosclerosis
Mach, F., & Steffens, S. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01685.x · Cited by 72
Acute kidney injury associated with synthetic cannabinoid use--multiple states, 2012.
(2013) · PubMed · Cited by 71
CB2 Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in Polymicrobial Sepsis
Csóka, B., Németh, Z. H., Mukhopadhyay, P., Spolarics, Z., Rajesh, M., Federici, S., Deitch, E. A., Bátkai, S., Pacher, P., & Haskó, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006409 · Cited by 67
Self-citationEndocannabinoid system modulation in cancer biology and therapy
Pisanti, S., & Bifulco, M. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.03.011 · Cited by 67
Acute Intoxication Caused by a Synthetic Cannabinoid in Two Adolescents
Heath, T. S., Burroughs, Z. T., Thompson, A. J., & Tecklenburg, F. (2012) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-17.2.177 · Cited by 66
Cannabinoid Type 2 Receptor as a Target for Chronic - Pain
Beltramo, M. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709787001785 · Cited by 62
Toxic Effects of Marijuana on the Cardiovascular System
Pratap, B., & Korniyenko, A. (2011) · Cardiovascular Toxicology · doi:10.1007/s12012-011-9150-y · Cited by 60
Endocannabinoids and cardiac contractile function: Pathophysiological implications
Bátkai, S., & Pacher, P. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.04.003 · Cited by 60
Self-citationLenglet, S., Thomas, A., Soehnlein, O., Montecucco, F., Burger, F., Pelli, G., Galan, K., Cravatt, B. F., Staub, C., & Steffens, S. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300275 · Cited by 58
Sticht, M. A., Long, J. Z., Rock, E. M., Limebeer, C. L., Mechoulam, R., Cravatt, B. F., & Parker, L. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01407.x · Cited by 57
Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells
Michalski, C. W., Maier, M., Erkan, M., Sauliunaite, D., Bergmann, F., Pacher, P., Bátkai, S., Giese, N. A., Giese, T., Frieß, H., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001701 · Cited by 56
Self-citationMarihuana as medicine. A plea for reconsideration.
Grinspoon, L., & Bakalar, J. B. (1995) · PubMed · Cited by 53
Novel Natural and Synthetic Ligands of the Endocannabinoid System
Hanus, L. O., & Mechoulam, R. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980096 · Cited by 51
The Effects of Cannabis on Heart Rate Variability and Well-Being in Young Men
Schmid, K., Schönlebe, J., Drexler, H., & Müeck‐Weymann, M. (2010) · Pharmacopsychiatry · doi:10.1055/s-0030-1248314 · Cited by 49
Possible Anandamide and Palmitoylethanolamide involvement in human stroke
Naccarato, M., Pizzuti, D., Petrosino, S., Simonetto, M., Ferigo, L., Grandi, F., Pizzolato, G., & Marzo, V. D. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-47 · Cited by 49
Effect of Rimonabant on Glycemic Control in Insulin-Treated Type 2 Diabetes: The ARPEGGIO Trial
Hollander, P. A., Amod, A., Litwak, L., Chaudhari, U., & for the ARPEGGIO Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0455 · Cited by 48
Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain
Palkovits, M., Harvey-White, J., Liu, J., Kovács, Z., Bobest, M., Lovas, G., Bagó, A. G., & Kunos, G. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.034 · Cited by 46
Self-citationKlumpers, L. E., Roy, C., Ferron‐Brady, G., Turpault, S., Poitiers, F., Pinquier, J., van Hasselt, J. G. C., Zuurman, L., Erwich, F. A. S., & van Gerven, J. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12071 · Cited by 40
Amorós, I., Barana, A., Caballero, R., Gómez, R. J., Osuna, L., Lillo, M. P., Tamargo, J. L., & Delpón, E. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.07.011 · Cited by 40
Therapeutic opportunities through modulation of the endocannabinoid system
Makriyannis, A., Mechoulam, R., & Piomelli, D. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.03.012 · Cited by 38
Targeting the Endocannabinoid System for the Treatment of Cancer – A Practical View
Fowler, C. J., Gustafsson, S. B., Chung, S. C., Persson, E., Jacobsson, S. O. P., & Bergh, A. R. J. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610791164201 · Cited by 37
Inhibitors of endocannabinoid breakdown for pain: Not so FA(AH)cile, after all
Marzo, V. D. (2012) · Pain · doi:10.1016/j.pain.2012.06.016 · Cited by 36
The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia.
Lamontagne, D., Lépicier, P., Lagneux, C., & Bouchard, J. (2006) · PubMed · Cited by 35
Brown, W. H., Gillum, M. P., Lee, H., Camporez, J. P., Zhang, X., Jeong, J. K., Alves, T. C., Erion, D. M., Guigni, B. A., Kahn, M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212887109 · Cited by 35
March, Z. D., Zuccato, C., Giampà, C., Patassini, S., Bari, M., Gasperi, V., CEBALLOS, M. L. D., Bernardi, G., Maccarrone, M., Cattaneo, E. F., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.11.044 · Cited by 32
2-Arachidonoylglycerol Increases in Ischemia–Reperfusion Injury of the Rat Liver
Kurabayashi, M., Takeyoshi, I., Yoshinari, D., Matsumoto, K., Maruyama, I., & Morishita, Y. (2005) · Journal of Investigative Surgery · doi:10.1080/08941930590905189 · Cited by 32
Diabetes Care: “State of the Union”
Cefalu, W. T. (2012) · Diabetes Care · doi:10.2337/dc12-2182 · Cited by 30
Cloning and pharmacological characterization of the dog cannabinoid CB2 receptor
Ndong, C., O’Donnell, D., Ahmad, S., & Groblewski, T. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.08.002 · Cited by 30
Kleyer, J., Nicolussi, S., Taylor, P., Simonelli, D., Furger, E., Anderle, P., & Gertsch, J. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.02.014 · Cited by 29
Cappellano, G., Uberti, F., Caimmi, P. P., Pietronave, S., Mary, D., Dianzani, C., Micalizzi, E., Melensi, M., Boldorini, R. L., Nicosia, G., et al. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.06.003 · Cited by 28
Carloni, S., Alconada, D. A., Girelli, S., Duranti, A., Tontini, A., Piomelli, D., Hilario, E., Alvarez, A. A., & Balduini, W. (2012) · Pediatric Research · doi:10.1038/pr.2012.91 · Cited by 22
Scheen, A. J., Gaal, L. G. V., Després, J., Pi-Sunyer, X., Golay, A., & Hanotin, C. (2006) · PubMed · Cited by 21
Grinspoon, L., Bakalar, J. B., Zimmer, L. E., & Morgan, J. P. (1997) · Science · doi:10.1126/science.277.5327.749a · Cited by 21
Rat and human fatty acid amide hydrolases: Overt similarities and hidden differences
Venere, A. D., Dainese, E., Fezza, F., Angelucci, C. B., Rosato, N., Cravatt, B. F., Finazzi‐Agrò, A., Mei, G., & Maccarrone, M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.07.021 · Cited by 20
Petrella, C., Agostini, S., Alemà, G., Casolini, P., Carpino, F., Giuli, C., Improta, G., Linari, G., Petrozza, V., & Broccardo, M. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01569.x · Cited by 19
Ishii, Y., Sakamoto, T., Ito, R., & Yanaga, K. K. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.01.026 · Cited by 16
Pacher, P., & Ungvari, Z. I. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00020.2008 · Cited by 15
Self-citationZyromski, N. J., Mathur, A., Pitt, H. A., Wade, T. E., Wang, S. S., Swartz‐Basile, D. A., Prather, A. D., & Lillemoe, K. D. (2009) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-009-0824-8 · Cited by 11
Sanchez, N. M., Valdés, D., Bahena, R. P., et al. (2007) · Cited by 10
Cited by
β‐caryophyllene and β‐caryophyllene oxide—natural compounds of anticancer and analgesic properties
Fidyt, K., Fiedorowicz, A., Strządała, L., & Szumny, A. (2016) · Cancer Medicine · doi:10.1002/cam4.816 · Cited by 674
Endocannabinoid signaling at the periphery: 50 years after THC
Maccarrone, M., Bab, I., Bíró, T., Cabral, G. A., Dey, S. K., Di Marzo, V., Konje, J. C., Kunos, G., Mechoulam, R., Pacher, P., et al. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.02.008 · Cited by 646
Self-citationCommensal bacteria make GPCR ligands that mimic human signalling molecules
Cohen, L. J., Esterhazy, D., Kim, S.-H., Lemetre, C., Aguilar, R. R., Gordon, E. A., Pickard, A. J., Cross, J. R., Emiliano, A. B., Han, S. M., et al. (2017) · Nature · doi:10.1038/nature23874 · Cited by 500
Ligresti, A., De Petrocellis, L., & Di Marzo, V. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 469
Early phytocannabinoid chemistry to endocannabinoids and beyond
Mechoulam, R., Hanuš, L. O., Pertwee, R., & Howlett, A. C. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3811 · Cited by 393
Metadata
- Authors
- Pacher, P., & Kunos, G.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2013-04-22
- Volume
- 280
- Issue
- 9
- Pages
- 1918-1943
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W2171530795
- Cited by
- 405
- References
- 277
- FWCI
- 31.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.